
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.690 | 124.710 | 120.020 |
Bonds | 2.220 | 2.220 | 0.000 |
Convertible | 93.080 | 93.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 7.383 | 19.479 |
Price to Book | 0.601 | 2.685 |
Price to Sales | 0.902 | 2.526 |
Price to Cash Flow | - | 13.755 |
Dividend Yield | 13.038 | 3.870 |
5 Years Earnings Growth | - | 15.069 |
Name | Net % | Category Average |
---|---|---|
Derivative | 0.236 | 68.517 |
Corporate | 94.947 | 88.002 |
Cash | 4.463 | 11.755 |
Number of long holdings: 190
Number of short holdings: 35
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Goldman Sachs International 0% | XS2688718373 | 1.52 | - | - | |
Rivian Automotive Inc 3.625% | - | 1.46 | - | - | |
Ping An Insurance (Group) Company of China Ltd. 0.875% | XS2859746237 | 1.45 | - | - | |
Snowflake Inc 0% | - | 1.13 | - | - | |
Affirm Holdings Inc 0.75% | - | 1.09 | - | - | |
Guardant Health Inc 1.25% | - | 1.09 | - | - | |
SBI Holdings Inc 0% | XS2857240316 | 1.06 | - | - | |
Rheinmetall AG 2.25% | DE000A30V8T1 | 1.06 | - | - | |
Gold Pole Capital Co Ltd. 1% | XS2849520650 | 1.05 | - | - | |
Bridgebio Pharma Inc 1.75% | - | 1.04 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Bond S Convert Global EUR I A3a | 4.64B | 14.36 | 10.87 | 5.95 | ||
UBS Bond S Convert Global EUR I A3e | 4.64B | 14.36 | 10.87 | 5.95 | ||
UBS Bond S Convert Global EUR P acc | 4.64B | 10.57 | 6.69 | 4.10 | ||
UBS Bond S Convert Global EUR P dis | 4.64B | 12.87 | 9.13 | 4.51 | ||
UBS Bond S Convert Global EUR Q dis | 4.64B | 13.63 | 10.12 | 5.45 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review